Cargando…
Treatment of Aggressive Antineutrophil Cytoplasmic Antibody–Associated Vasculitis With Eculizumab
Autores principales: | Huizenga, Noah, Zonozi, Reza, Rosenthal, Jillian, Laliberte, Karen, Niles, John L., Cortazar, Frank B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136349/ https://www.ncbi.nlm.nih.gov/pubmed/32274460 http://dx.doi.org/10.1016/j.ekir.2019.11.021 |
Ejemplares similares
-
Eculizumab and Complement Activation in Anti−glomerular Basement Membrane Disease
por: Nithagon, Pravarut, et al.
Publicado: (2021) -
Treatment of Gemcitabine-Induced Thrombotic Microangiopathy Followed by Gemcitabine Rechallenge With Eculizumab
por: Efe, Orhan, et al.
Publicado: (2021) -
Antineutrophil Cytoplasmic Antibody and Multiple Sclerosis
por: George, Jason C., et al.
Publicado: (2017) -
Antineutrophil Cytoplasmic Autoantibody–Associated Glomerulonephritis Following the Pfizer-BioNTech COVID-19 Vaccine
por: Dube, Geoffrey K., et al.
Publicado: (2021) -
Eculizumab in Early-Stage Pregnancy
por: Morales, Enrique, et al.
Publicado: (2020)